Pharmacological screening of substances with cardioprotective effect in the group of 3-oxypyridine derivatives
Authors:
- Lyudmila M. DanilenkoLDLyudmila M. Danilenko
- Sophiya Ya. SkachilovaSSSophiya Ya. Skachilova
- Sergey V. NadezhdinSNSergey V. Nadezhdin
- Alena S. TimokhinaATAlena S. Timokhina
- Olesya V. ShcheblykinaOSOlesya V. Shcheblykina
- Alla S. KotelnikovaAKAlla S. Kotelnikova
Open Access
- 21 June 2018
- journal article
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 4 (2) , 125-131
Abstract
Introduction: The search for new compounds with antihypoxic and cardioprotective effects among 3-oxypyridine derivatives is promising. Research objectives: To study the anti-hypoxic and cardioprotective effects of 3-oxypyridine derivatives. Materials and methods: The search for compounds with an antihypoxic effect was carried out on blood leukocytes of rats in in vitro. To simulate hypoxia, Oil for Tissue Culture (SAGE) was used, 500 µl of which was applied into wells over a growth medium in order to block gas exchange. The cardioprotective effect of 3-oxypyridine derivatives was studied in the model of coronary-occlusive myocardial infarction (30 minutes of ischemia, 90 minutes of reperfusion). The level of troponin I (Tn I) was determined as a biochemical marker of myocardial damage. Results and discussion: In the in vitro experiments, when culting white blood cells, the lead compound in the group of 3-oxypyridine derivatives was identified under code LKhT 21–16, which increases the number of viable cells in the presence of hypoxia, surpassing the reference drugs. When confirming the chemical structure of the lead compound, LHT 21–16, a high sensitivity of the NMR spectroscopy method was revealed. In studying the cardioprotective activity in the model of coronary-occlusive myocardial infarction compound LHT 21–16 exerted a marked cardioprotective effect when reducing the size of the necrotic zone and the level of biochemical marker Tn I. Conclusions: 3-oxypiridine derivatives have antihypoxic and cardioprotective effects, which shows in a high number of surviving cells in the presence of hypoxia in the in vitro model, a reduced size of the necrotic zone and a reduced level of Tn I in the coronary-occlusive myocardial infarction.Keywords
This publication has 18 references indexed in Scilit:
- Effects of Oxygen Concentrations on Postresuscitation Myocardial Oxidative Stress and Myocardial Function in a Rat Model of Cardiopulmonary ResuscitationCritical Care Medicine, 2015
- The effect of 3-oxypiridine and succinic acid derivatives on the resistance to acute cerebral ischemiaS.S. Korsakov Journal of Neurology and Psychiatry, 2014
- Antioxidant therapy of endothelialdysfunctionReviews on Clinical Pharmacology and Drug Therapy, 2013
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological CardioprotectionAntioxidants & Redox Signaling, 2013
- Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioningJournal of Cardiovascular Medicine, 2009
- Deferiprone Does Not Protect against Chronic Anthracycline Cardiotoxicity in VivoThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Fluorescent Viability Stains Overestimate Chondrocyte Viability in Osteoarticular AllograftsThe American Journal of Sports Medicine, 2007
- Does Trimetazidine Exert Cytoprotective Activity on Astrocytes Subjected to Hypoxia In Vitro?NeuroToxicology, 2001
- Trimetazidine: In Vitro Influence on Heart Mitochondrial FunctionThe American Journal of Cardiology, 1995
- Effect of a 3-hydroxypyridine derivative membrane modulator on pharmacological activity of some psychotropic drugsBulletin of Experimental Biology and Medicine, 1985